Citadel Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Buy
+15,300
New +$274K ﹤0.01% 10839
2025
Q4
Sell
-15,200
Closed -$188K 12791
2025
Q3
$188K Sell
15,200
-700
-4% -$8.21K ﹤0.01% 11320
2025
Q2
$183K Buy
15,900
+6,000
+61% +$71.2K ﹤0.01% 10757
2025
Q1
$148K Sell
9,900
-5,500
-36% -$92.1K ﹤0.01% 10891
2024
Q4
$267K Sell
15,400
-7,800
-34% -$151K ﹤0.01% 9898
2024
Q3
$430K Buy
23,200
+12,600
+119% +$253K ﹤0.01% 8585
2024
Q2
$215K Sell
10,600
-111,000
-91% -$1.96M ﹤0.01% 9773
2024
Q1
$2.08M Sell
121,600
-5,600
-4% -$88.1K ﹤0.01% 5445
2023
Q4
$2.25M Buy
127,200
+105,000
+473% +$2.12M ﹤0.01% 5157
2023
Q3
$533K Buy
22,200
+3,100
+16% +$76.1K ﹤0.01% 7925
2023
Q2
$444K Sell
19,100
-8,100
-30% -$183K ﹤0.01% 8201
2023
Q1
$600K Buy
27,200
+4,500
+20% +$105K ﹤0.01% 7943
2022
Q4
$460K Sell
22,700
-3,500
-13% -$67.8K ﹤0.01% 8417
2022
Q3
$353K Sell
26,200
-11,000
-30% -$185K ﹤0.01% 9211
2022
Q2
$737K Buy
37,200
+16,000
+75% +$425K ﹤0.01% 7735
2022
Q1
$671K Sell
21,200
-12,500
-37% -$350K ﹤0.01% 8669
2021
Q4
$752K Sell
33,700
-1,500
-4% -$39.1K ﹤0.01% 8645
2021
Q3
$977K Sell
35,200
-26,100
-43% -$795K ﹤0.01% 8214
2021
Q2
$2.39M Sell
61,300
-24,600
-29% -$882K ﹤0.01% 6161
2021
Q1
$2.47M Buy
85,900
+69,000
+408% +$2.36M ﹤0.01% 5903
2020
Q4
$448K Sell
16,900
-15,100
-47% -$308K ﹤0.01% 8349
2020
Q3
$488K Sell
32,000
-5,600
-15% -$117K ﹤0.01% 7345
2020
Q2
$764K Sell
37,600
-1,800
-5% -$32.3K ﹤0.01% 6327
2020
Q1
$407K Buy
39,400
+7,700
+24% +$215K ﹤0.01% 6798
2019
Q4
$1.19M Buy
31,700
+11,300
+55% +$508K ﹤0.01% 5277
2019
Q3
$951K Sell
20,400
-10,600
-34% -$493K ﹤0.01% 5683
2019
Q2
$1.62M Sell
31,000
-20,900
-40% -$1.23M ﹤0.01% 4883
2019
Q1
$3.58M Buy
51,900
+19,800
+62% +$1.33M ﹤0.01% 3479
2018
Q4
$1.92M Sell
32,100
-5,400
-14% -$466K ﹤0.01% 4216
2018
Q3
$4.34M Buy
37,500
+26,600
+244% +$3M ﹤0.01% 3175
2018
Q2
$1.38M Sell
10,900
-2,800
-20% -$341K ﹤0.01% 4679
2018
Q1
$1.48M Sell
13,700
-31,600
-70% -$3.5M ﹤0.01% 4192
2017
Q4
$4.96M Buy
45,300
+18,200
+67% +$1.82M ﹤0.01% 2488
2017
Q3
$2.67M Sell
27,100
-3,600
-12% -$349K ﹤0.01% 3062
2017
Q2
$3.11M Buy
30,700
+13,100
+74% +$1.41M ﹤0.01% 2618
2017
Q1
$2.03M Sell
17,600
-13,100
-43% -$1.52M ﹤0.01% 3057
2016
Q4
$3.69M Buy
30,700
+8,800
+40% +$974K ﹤0.01% 2299
2016
Q3
$2.46M Sell
21,900
-15,800
-42% -$1.82M ﹤0.01% 2733
2016
Q2
$4.67M Sell
37,700
-8,800
-19% -$1.06M 0.01% 1877
2016
Q1
$5.23M Buy
46,500
+24,300
+109% +$2.52M 0.01% 1726
2015
Q4
$2.41M Sell
22,200
-17,800
-45% -$2.04M ﹤0.01% 2554
2015
Q3
$3.99M Sell
40,000
-800
-2% -$87K ﹤0.01% 2173
2015
Q2
$4.65M Buy
40,800
+8,300
+26% +$1.01M ﹤0.01% 2135
2015
Q1
$3.4M Buy
32,500
+12,500
+63% +$1.33M ﹤0.01% 2446
2014
Q4
$2.41M Sell
20,000
-9,100
-31% -$1.2M ﹤0.01% 2694
2014
Q3
$4.26M Buy
29,100
+16,700
+135% +$2.58M ﹤0.01% 2129
2014
Q2
$2.07M Sell
12,400
-10,100
-45% -$1.8M ﹤0.01% 2708
2014
Q1
$4.46M Buy
22,500
+2,200
+11% +$415K 0.01% 1885
2013
Q4
$3.88M Buy
20,300
+9,200
+83% +$1.71M 0.01% 1892
2013
Q3
$1.88M Sell
11,100
-2,100
-16% -$326K ﹤0.01% 2466
2013
Q2
$2M Buy
+13,200
New +$1.87M ﹤0.01% 2493

Other funds holding CLB

Citadel Advisors's CLB Position: Q1 2026 in Review

Citadel Advisors increased its Core Laboratories (CLB) stake by 319% in Q1 2026, buying an estimated $2.11M and bringing the position to 154,800 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #5541.

Citadel Advisors first reported a position in CLB in Q2 2013 and has held it in 46 quarters since. The position peaked at $44.3M in Q1 2019. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Citadel Advisors held 154,800 shares of Core Laboratories worth $2.6M as of Q1 2026.
  • Citadel Advisors bought 117,867 Core Laboratories shares in Q1 2026, an estimated $2.11M.
  • Core Laboratories made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5541 holding.
  • Citadel Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 46 quarters since.
  • Citadel Advisors's Core Laboratories position peaked at $44.3M in Q1 2019.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.